Literature DB >> 9874701

Influence of gender on prednisolone effects on whole blood T-cell deactivation and trafficking in rats.

G M Meno-Tetang1, J V Gobburu, W J Jusko.   

Abstract

Prednisolone (5 mg/kg intravenous) was administered to adrenalectomized male and female Sprague-Dawley rats (250-350 g) to assess the effects of gender on disposition and pharmacoimmunodynamics. Plasma concentrations of prednisolone were determined by high-performance liquid chromatography. Incorporation of [3H]thymidine (3H-TDR) was used to determine whole blood T-cell (WBTC) trafficking and deactivation following stimulation with Concanavalin-A. Whole blood T-cell trafficking was determined indirectly by using the glucocorticoid receptor antagonist RU-40555 (250 ng/mL) added to ex vivo cultures of whole blood from animals dosed with prednisolone. Mean (+/- SD) prednisolone clearance values were 3.22 +/- 0.88 and 3.46 +/- 0.96 L/h/kg in males and females, respectively. After administration of prednisolone, relative T-cell counts decreased slowly with time to reach a nadir at 3-5 h and returned to baseline levels by 8 h. Fitting data using an indirect response model yielded mean prednisolone 50% inhibitory concentration for inhibition of WBTC trafficking (IC50T) that was lower in males compared with females (0.14 +/- 0.16 versus 1.03 +/- 0.06 ng/mL; p < 0.05). In the absence of RU-40555, an immediate and complete inhibition of 3H-TDR incorporation into WBTC was observed (deactivation) and baseline levels were recovered slowly as prednisolone was cleared from blood. The mean 50% inhibitory concentration for inhibition of WBTC deactivation (IC50D) based on an inhibitory Imax model was similar in males and females (0.20 +/- 0.24 versus 0.18 +/- 0.12 ng/mL). Although male and female rats have similar exposure to prednisolone after 5-mg/kg doses, males are more sensitive to the inhibition of WBTC trafficking, whereas no gender effects on deactivation of WBTC exist.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9874701      PMCID: PMC4207271          DOI: 10.1021/js9802695

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  26 in total

Review 1.  Anti-inflammatory actions of steroids: molecular mechanisms.

Authors:  P J Barnes; I Adcock
Journal:  Trends Pharmacol Sci       Date:  1993-12       Impact factor: 14.819

2.  Increased cardiac allograft rejection in female heart transplant recipients.

Authors:  B G Crandall; D G Renlund; J B O'Connell; N A Burton; K W Jones; W A Gay; D B Doty; S V Karwande; H R Lee; C Holland
Journal:  J Heart Transplant       Date:  1988 Nov-Dec

3.  Corticosteroid analysis in biological fluids by high-performance liquid chromatography.

Authors:  J Q Rose; W J Jusko
Journal:  J Chromatogr       Date:  1979-03-01

4.  Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent.

Authors:  B B Turner
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

5.  Pharmacodynamic modeling of lymphocytopenia and whole blood lymphocyte cultures in prednisolone-treated individuals.

Authors:  E Bloemena; R P Koopmans; S Weinreich; C J van Boxtel; P T Schellekens
Journal:  Clin Immunol Immunopathol       Date:  1990-12

6.  Specific estrogen binding sites in human lymphoid cells and thymic cells.

Authors:  L Danel; G Souweine; J C Monier; S Saez
Journal:  J Steroid Biochem       Date:  1983-05       Impact factor: 4.292

7.  Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.

Authors:  K H Lew; E A Ludwig; M A Milad; K Donovan; E Middleton; J J Ferry; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1993-10       Impact factor: 6.875

8.  Physiological concentration of estradiol inhibits polymorphonuclear leukocyte chemotaxis via a receptor mediated system.

Authors:  I Ito; T Hayashi; K Yamada; M Kuzuya; M Naito; A Iguchi
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

9.  The influence of estradiol and tamoxifen on the mixed lymphocyte reaction in rats.

Authors:  E Baral; S Kwok; I Berczi
Journal:  Immunopharmacology       Date:  1991 May-Jun

10.  Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures.

Authors:  T Paavonen; L C Andersson; H Adlercreutz
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

Review 2.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

3.  Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation.

Authors:  Mindy He Magee; Robert A Blum; Christian D Lates; William J Jusko
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

4.  A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing.

Authors:  Alexander R Vernon; Roy M Pemberton; H Ruth Morse
Journal:  Mutagenesis       Date:  2022-05-04       Impact factor: 2.954

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.